Subjective benefit of inhaled therapies in patients with bronchiectasis: A questionnaire study

International Journal of Clinical Practice

Volumn 58, Issue 5, 2004, Pages 441-443

  O'Neill, B ^a,b   Bradley, J M ^a,b   Macmahon, J ^a   Elborn, Stuart ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Bronchiectasis; Inhaled therapies; Subjective benefit

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BRONCHIECTASIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFORMATION PROCESSING; INHALER; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL INFORMATION; NEBULIZER; PATIENT ATTITUDE; PRIORITY JOURNAL; QUESTIONNAIRE; SPIROMETRY; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; BRONCHIECTASIS; BRONCHODILATOR AGENTS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 2942703746     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1368-5031.2004.00001.x     Document Type: Article

References (13)

1. Currie DC. Nebulisers for bronchiectasis. Thorax 1997; 52 (S2): S72-S74.
2. Elborn JS, Johnston B, Allen F, Clarke J, McGarry J, Varghese G. Inhaled corticosteroids in patients with bronchiectasis. Resp Med 1992; 86: 121-4.
3. Kolbe J, Wells A. Ram FSF. Inhaled corticosteroids for bronchiectasis (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 2000.
4. Tsang KW, Ho P, Lam W et al. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis. Am J Respir Crit Care Med 1998; 158: 723-7.
5. Hassan JA, Saadiah S, Roslan H, Zainudin BMZ. Bronchodilator response to inhaled beta-2 agonist and anticholergic drugs in patients with bronchiectasis. Respirology 1999; 4: 423-6.
6. Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax 2001; 56: 880-7.
7. Haynes C, Jones P, O'Leary C, Hansell DM, Cole PJ, Wilson R. Comparison of quality of life measures, and extent of disease measured by CT scan in bronchiectasis. Qual Life Res 1995; 4: 437-9.
8. British Thoracic Society Guidelines for the Management of Chronic Obstructive Pulmonary Disease. Thorax 1997; 52 (S5): S1-S28.
9. Quanger P. Standardised lung function testing. Report Working Party for the European Community for Steel and Coal. Eur Respir J 1993; 6(S16): S13-S102.
10. British Thoracic Society Guidelines for the Measurement of Respiratory Function. Respir Med 1994: 165-94.
11. McAlister O, Bradley JM, Elborn JS. Perceived benefits of inhaled therapies in cystic fibrosis. BJTR 2002; 9: 1-5.
12. Norgrady SG, Evan WV, Davies BH. Reversibility of airways obstruction in bronchiectasis. Thorax 1978; 33: 635-7.
13. Current best practice for nebuliser treatment. Thorax 1997; 52 (S2): S1-S106.